Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Specialty Generics Market Grow Over the Forecast Period Based on Its Expected CAGR?

Over the past few years, the specialty generics market has seen rapid expansion. This market is predicted to expand from $95.87 billion in 2024 to $108.11 billion in 2025, displaying a compound annual growth rate (CAGR) of 12.8%. The previous growth surge in this market can be attributed to various factors such as the expiry of patents for branded drugs, a rising demand for cost-effective alternatives, increased regulatory support for the approval of generic drugs, growing pressures on healthcare costs, an increase in chronic diseases, and an aging population.

In the coming years, we anticipate quick expansion in the specialty generics market, with its value expected to reach $189.72 billion in 2029, reflecting a compound annual growth rate (CAGR) of 15.1%. This forecasted growth can be linked to several factors including the broadening of the biosimilars market, an intensified focus on the development of complex generic drugs, a rising interest in specialty generic injectables, the use of 3D printing technology in specialty generic manufacturing, and an emerging market growth. The period also highlights major trends like personalization and targeting of specialty generics, strategic associations and collaborations in generic drug development, focus on creating abuse-resistant formulations, incorporation of digital health technologies in specialty generics, and regulatory efforts for faster approval of complex generics.

What Strategic Factors Are Influencing the Accelerated Growth of the specialty generics Market?

A rise in chronic illnesses is anticipated to drive the specialty generic market’s growth. These persistent ailments are often incurable but can sometimes be managed or even cured. Lifestyle changes, dietary habits, and failure to maintain a healthy weight contribute to these long-term diseases, with some even posing a risk of developing into cancer. The increasing prevalence of these conditions underlines the necessity of specialty generics in treating complex chronic diseases. For example, in September 2022, the World Health Organization, a specialized United Nations agency based in Switzerland, reported 41 million global deaths annually due to non-communicable or chronic diseases, constituting 74% of total deaths. The figures included 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Consequently, the escalating incidence of chronic diseases is fueling the growth of the specialty generic market.

Request Your Free Specialty Generics Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=7781&type=smp

Who Are the Dominant Players Expanding Their Reach in the Specialty Generics Market?

Major companies operating in the specialty generics market include:

• Teva Pharmaceutical Industries Ltd._x000D_

• Endo International plc_x000D_

• Akorn Operating Company LLC_x000D_

• Mallinckrodt Pharmaceuticals_x000D_

• Dr. Reddy’s Laboratories Ltd._x000D_

What Are the Top Trends Shaping the Evolution of the Specialty Generics Market?

Leading corporations in the specialty generic market, such as Lisdexamfetamine Dimesylate, are being authorized to meet the urgent demand for medication. Approval in specialty generics is the regulatory permission issued for drugs that are bioequivalent and therapeutically equal to proprietary specialty medicines typically used to treat intricate or rare health conditions once their patent protection has lapsed. For example, Mallinckrodt plc, a specialty pharmaceutical company based in Ireland, was granted FDA approval in August 2023 for its Lisdexamfetamine Dimesylate Capsules under the SpecGx LLC Specialty Generics division to treat Attention-Deficit/Hyperactivity Disorder (ADHD). Lisdexamfetamine Dimesylate is a kind of specialty generic and a federally regulated substance (CII) used for treating ADHD and other conditions.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/specialty-generics-global-market-report

Which Key Segments of the Specialty Generics Market Are Poised for Growth and Innovation?

The specialty generics market covered in this report is segmented –

1) By Route Of Administration: Injectables, Oral, Other Route Of Administration

2) By Indication: Oncology, Autoimmune Diseases, Infectious Diseases, Other Indication

3) By Distribution Channel: Retail Pharmacies, Specialty Pharmacies, Hospital Pharmaciesx

Subsegments:

1) By Injectables: Intravenous (IV) Injectables, Intramuscular (IM) Injectables, Subcutaneous (SC) Injectables

2) By Oral: Tablets, Capsules, Liquid Formulations

3) By Other Route Of Administration: Topical, Transdermal, Inhalation

Which Regions Are Setting the Pace for Specialty Generics Market Growth?

North America was the largest region in the specialty generics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specialty generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Defines the Scope of the Specialty Generics Market?

The specialty generics refer to generic versions of drugs used to describe expensive, intricate, or high-touch generic versions of medications. It requires substantial service participation to manage. This specialty generic includes biologics and biosimilars, which have separate regulatory routes. The majority of specialty medications are used to treat various malignancies, rheumatoid arthritis, and multiple sclerosis.

Browse Through More Similar Reports By The Business Research Company:

Gastrointestinal Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Pharmacies and Drug Stores Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmacies-and-drug-stores-global-market-report

Nutritional Feed Additives Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nutritional-feed-additives-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: